10 Apricus Biosciences Analyst Ratings, Earnings, Dividends and Insider Trades | $APRI | NASDAQ:APRI | Analyst Ratings Network

Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Apricus Biosciences Company Profile (NASDAQ:APRI)

Consensus Ratings for Apricus Biosciences (NASDAQ:APRI) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: $2.50 (5.93% upside)

Analysts' Ratings History for Apricus Biosciences (NASDAQ:APRI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/19/2014Cantor FitzgeraldBoost Price Target$2.00 -> $2.50ViewTweet This Rating  Share This Rating on StockTwits
8/23/2013Cantor FitzgeraldInitiated CoverageHold$2.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2013JMP SecuritiesLower Price TargetMarket Outperform$6.00 -> $5.00ViewTweet This Rating  Share This Rating on StockTwits
7/27/2012Lazard Ltd.Initiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
7/23/2012Ascendiant Capital MarketsInitiated CoverageStrong-Buy$6.00ViewTweet This Rating  Share This Rating on StockTwits
6/14/2012JMP SecuritiesInitiated CoverageOutperform$6.00ViewTweet This Rating  Share This Rating on StockTwits
6/6/2012Roth CapitalInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/24/2012 forward)